1986
DOI: 10.1097/00004872-198610000-00012
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Ouabain on Blood Pressure Regulation in Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
11
0

Year Published

1990
1990
2004
2004

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 26 publications
(13 citation statements)
references
References 0 publications
2
11
0
Order By: Relevance
“…Differences in the experimental protocols can explain these different results. First, in the study by Yasujima et al 13 BP was measured for only 2 to 6 days after the initiation of intravenous ouabain infusion. Sekihara et al 12 injected ouabain only once a week.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Differences in the experimental protocols can explain these different results. First, in the study by Yasujima et al 13 BP was measured for only 2 to 6 days after the initiation of intravenous ouabain infusion. Sekihara et al 12 injected ouabain only once a week.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, pressor responses to norepinephrine were enhanced by low doses of ouabain 18 but attenuated by high doses. 13 The mechanisms responsible for chronic ouabaininduced hypertension in normotensive rats are not yet clear. Ouabain-induced hypertension was associated with an increase in TPR, 15 and it was postulated 15 that an inhibition of Na + ,K + -ATPase in vascular smooth muscle cells is responsible for the TPR increase.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, we also assumed that digoxin at the dose employed, attained effective levels to inhibit Nat, K+-ATPase, since the plasma levels of digoxin attained in the present experiments was approximately 1,000 fold more than those in digitalized man (1-3 ng/ml). The antihypertensive effect of ouabain, in rats made hypertensive by NE has been previously reported from our laboratory (Yasujima et al 1986b). Based on the previous and present findings, it is reasonable to assume that the attenuation by cardiac glycosides of the blood pressure elevation induced by chronic infusion of NE may be generalized to all cardiac glycosides.…”
Section: Discussionmentioning
confidence: 67%
“…However, we have previously demonstrated that chronic administration of ouabain, a cardiac glycoside, failed to induce any significant changes in blood pressure and sodium excretion in rats (Yasujima et al 1986b). On the contrary, continuous infusion of ouabain was effective in counteracting the hypertensive action of norepinephrine (NE) infused chronically (Yasujima et al 1986b).…”
mentioning
confidence: 95%
“…[3][4][5][6] Other studies, however, have failed to demonstrate a hypertensive effect of ouabain in rats, [7][8][9] sheep, 10 dogs, 11 and humans. 12 The diverging results in rats could be linked to differences in the doses and duration of ouabain administration in the strains used or in the methods used for blood pressure measurement.…”
mentioning
confidence: 99%